PLASMA CELL LEUKEMIA

This study is testing a specific type of stem cell transplant using donated umbilical cord blood to treat patients with serious blood cancers and disorders. The procedure involves high-dose chemotherapy and radiation to wipe out the patient's diseased bone marrow before infusing …

This study is testing a gentler, slower approach to starting treatment for very frail patients with multiple myeloma, a type of blood cancer. Researchers want to see if starting with two drugs and slowly adding a third helps patients stick with treatment longer and feel better. T…

This study is testing a new cell therapy for patients whose blood cancers have returned or not responded to standard treatments. Researchers are giving patients specially engineered immune cells, called NK cells, which come from donated cord blood. The goal is to see if these mod…

This study is testing whether adding two rounds of CAR-T cell therapy to standard chemotherapy and a stem cell transplant can better control a rare and aggressive blood cancer called plasma cell leukemia. The treatment involves initial chemotherapy, followed by CAR-T cells, more …

This program provides early access to the drug venetoclax for patients with certain blood cancers like leukemia and lymphoma before it is fully approved in their country. It is for patients who have no other suitable treatment options and do not qualify for ongoing clinical trial…

This study is creating a large registry to track the health of older adults (age 50+) with blood cancers like multiple myeloma. Researchers will collect information through questionnaires and simple physical tests to understand how frailty and aging affect these patients. The goa…

This study aims to collect and store blood and tissue samples from 6,000 patients with multiple myeloma and related conditions. Researchers will gather samples and track treatment information over time to create a resource for future studies. The goal is to help scientists better…

This study is creating a large registry of 2000 adults with plasma cell disorders like multiple myeloma and amyloidosis. Participants complete health assessments about their daily function, medical conditions, and quality of life over time, and can optionally give blood samples f…